glp-1 vs sglt2 diabetes Inhibitors vs. Agonists to Treat the Heart, the Kidneys and the Brain Cardiovascular outcome studies in type
Description
Expanding therapeutic indications beyond diabetes into obesity treatment multiplies the addressable market size
Instead, CMS is extending the duration of a separate short-term program, called the Medicare GLP-1 Bridge, which was originally scheduled to run from July-December 2026 but will now run through the end of 2027
doi:10.1152/ajpendo.2001.281.1.E155 Garber AJ
Nausea initialization onto GLP-1 therapies can cause significant nausea
If approved for sleep apnea: Coverage is good for 1 year
Natural GLP-1 support supplements (berberine, Reducose, omega-3s, and similar) are sold as food supplements under UK food law
